The European market for soft tissue repair devices will experience steady growth over the forecast period. The economic situation continues to affect the European market because many health care facilities are opting for lower-cost products whenever possible. Although hindered by their high cost, there is a strong preference for premium-priced devices - such as biologic hernia meshes and composite synthetic mesh for VHR, synthetic PFR kits, and proprietary meshes for IHR - which offer clinical and technical advantages over lower-cost devices. In the vaginal sling and pelvic floor reconstruction (PFR) device markets, the recent Food and Drug Administration (FDA) public health notification regarding adverse events associated with soft tissue repair devices for urogynecological indications will affect procedure volumes in Europe, and also place a higher emphasis on the need for strong clinical data. Overall, favorable demographics through the growing elderly population in Europe and rising obesity rates will result in steady market expansion over the forecast period.
Browse more Orthopedic Market Research Reports